Rate and characteristics of asthma exacerbations: The ASMAB I study;Tasa y características de las agudizaciones asmáticas (ASMAB I)

Archivos de Bronconeumologia

Volumn 44, Issue 6, 2008, Pages 303-311

  Morell, Ferran ^a,b   Genover, Teresa ^c   Muñoz, Xavier ^a,b   García Aymerich, Judith ^d   Ferrer, Jaume ^a,b   Cruz, María Jesús ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Asthma exacerbation; Comorbidity; Emergency services; Epidemiology; Hospital admission; Readmission; Severe asthma exacerbation

Indexed keywords

ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; LEUKOTRIENE ANTIBODY; THEOPHYLLINE;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; CONFIDENCE INTERVAL; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; HOME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POPULATION; PRESCRIPTION; RATING SCALE; SPAIN; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 48249131252     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13123087     Document Type: Article

References (42)

1. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks and use asthma medication in the European Community Respiratory Health Survey. Eur Respir J. 1996;9:687-95.
2. Asthma Burden. European lung white book. Huddersfield: European Respiratory Society Journals; 2003. p. 16-25.
3. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-7.
4. Adams RS, Fuhlbrigge A, Guilbert T. Inadequate use of asthma medication in the United States: results of the Asthma in America National Population Survey. J Allergy Clin Immunol. 2002;110:58-64.
5. Stoloff SW, Boushey HA. Severity, control and responsiveness in asthma. J Allergy Clin Immunol. 2006;117:544-8.
6. Rees J. Asthma control in adults. BMJ. 2006;332:767-71.
7. Lemanske RF, Busse WW. Asthma: factors underlying inception, exacerbation, and disease progression. J Allergy Clin Immunol. 2006;117:S456-61.
8. Murray CS, Simpson A, Custovic A. Allergens, viruses and asthma exacerbations. Proc Am Thor Soc. 2004;1:99-104.
9. Sunyer J, Antó JM, Rodrigo MJ, Morell F. Case-control study of serum immunoglobulin-E antibodies reactive with soybean in epidemic asthma. Lancet. 1989;1:179-81.
10. Antó JM, Sunyer J, Reed CE, Sabria J, Martínez F, Morell F, et al. Preventing asthma epidemics due to soybeans by dust-control measures. N Engl J Med. 1993;329:1760-3.
11. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop report. NHI publication 1995, N.o 02-3659. Update of Executive Committee Report in 2002. p.136. Disponible en: www.ginasthma.com
12. Abramson MJ, Bailey MJ, Couper FJ, Driver JS, Drummer OH, Forbes AB, et al, and Victorian Asthma Mortality Study Group. Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med. 2001;163:12-8.
13. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop report. p. 68. Disponible en: www.ginasthma.com
14. Departament d'Estadística. Ajuntament de Barcelona. Disponible en: www.bcn.es/estadistica/
15. Grupo Español del Estudio Europeo del Asma. Estudio Europeo del asma. Prevalencia de síntomas relacionados con el asma en cinco áreas españolas. Med Clin (Barc). 1995;104:487-92.
16. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest. 2004;125:1081-102.
17. Plaza V, Serrano J, Picado C, Sanchis J, High Risk Asthma Research Group. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J. 2002;19:846-52.
18. Salmeron S, Liard R, Elkharrat D, Muir J, Neukirch F, Ellrodt A. Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study. Lancet. 2001;358:629-35.
19. Barr RG, Woodruff PG, Clark S, Camargo CA Jr. Sudden-onset asthma exacerbations: clinical features response to therapy, and 2-week follow-up. Eur Respir J. 2000;15:266-73.
20. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop report. p. 134. Disponible en: www.ginasthma.com
21. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-51.
22. Johston NW, Sears MR. Asthma exacerbations. Thorax. 2006;61:722-8.
23. Blair L, Suissa S, Boivin JE. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax. 1998;53:1025-9.
24. Kikuchi Y, Okabe S, Tamura G, Hida W, Homma M, Shirato K, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med. 1994;330:1329-34.
25. Morell F, Genover T, Reyes L, Benaque E, Roger A, Ferrer J. La población de asmáticos ambulatorios y su control tras adaptar el tratamiento a las recomendaciones internacionales (ASMACAP I). Arch Bronconeumol. 2007;43:29-35.
26. O'Bryne PM. Pharmacologic interventions to reduce the risk of asthma exacerbations. Proc Am Thorax Soc. 2004;1:105-8.
27. Ernst P, Spitzer WO, Suissa S, Cockroft D, Habbick B, Horwitz RI, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA. 1992;268:3462-4.
28. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332-6.
29. Haro M, Lazaro C, Martin C, Andicoberry MJ, Martínez MD. Utilidades de la enseñanza del manejo del cartucho presurizado y el sistema Turbuhaler® en los pacientes hospitalizados. Arch Bronconeumol. 2002;38:306-10.
30. Ordoñez GA, Phelan PD, Olinsky A, Roberston CF. Preventable factors in hospital admissions for asthma. Arch Dis Child. 1998;78:143-7.
31. Van Ganse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, et al. Persistent asthma: disease control, resource utilisation and direct cost. Eur Respir J. 2002;20:260-7.
32. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids (Cochrane review). En: The Cochrane Library. 2003(4). Oxford: Update software.
33. McFadden ER Jr, Elsanadi N, Dixon L, Takacs M, Deal EC, Boyd KK, et al. Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med. 1995;99:651-61.
34. Singh AK, Cydulka RK, Stahmer SA, Woodruff PG, Camargo CA Jr. Sex differences among adults presenting to the emergency department with acute asthma. Multicenter Asthma Research Collaboration Investigators. Arch Intern Med. 1999;159:1237-43.
35. Mitchell I, Tough SC, Semple LK, Green FH, Hessel PA. Near-fatal asthma: a population-based study of risk factors. Chest. 2002;121:1407-13.
36. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med. 2003;168:740-59.
37. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003;22:470-7.
38. Shaheen SO. Obesity and asthma: cause for concern? Clin Exp Allergy 1999;29:291-3.
39. Lenhardt R, Malone A, Grant EN, Weiss KB. Trends in Emergency Department Asthma Care in Metropolitan Chicago. Chest. 2003;124:1774-80.
40. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. (Cochrane Review). En: Cochrane Library. 2002(2). Oxford: Update software.
41. Emerman CL, Woodruff PG, Cydulka RK, Gibbs MA, Pollack CV Jr, Camargo CA Jr. Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration. Chest. 1999;115:919-27.
42. Johnston SL, Blasi F, Black PN, Martin RJ, Farrel DJ, Nieman RB. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med. 2006;354:1589-600.